Tagged with IP

Hutchison Medipharma You began your career at Pfizer, working your way up the organizational ladder, when suddenly you decided to come to China back in 2001, well before China was on the map for R&D. What drove you to make this choice, to take the risk and come to China? It wasn’t…

Beaufour IPSEN China Your background before joining Beaufour Ipsen is quite unique among country managers of pharmaceutical companies: working many years in academia and focused very much on Asian studies. What brought you to the pharmaceutical industry? I have a very long personal history with China, starting back in my student days. I…

Association of International Pharmaceutical Manufactures (AIPM) When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite similar to yours: he had been an administrator and head of the regulatory authority; he subsequently left the administration and…

Ipsen Ukraine Ipsen has showed some very positive results worldwide in 2010 and so far this year, specifically in non-Western European markets that grew by 12% in 2010. How have the Ukrainian operations of Ipsen been faring in comparison to the global performance of the company? Let me first provide you a…

Philips Russia After a long history in Philips, this is your first tenure as a regional CEO. Having been at this position for less than a year, what are your impressions of the differing challenges for a regional head relative to a business unit manager? There are quite distinct challenges. As someone…

Ipsen Russia Ipsen has recently announced the acquisition of a Russian pharmaceutical license. Even before this license, Russia was already one of the largest affiliates. of the group, as of 2010. The company is clearly digging in for the long term. What does this additional step imply for operations here? You are…

Sandoz Philippines Corporation Mr. Willis, you have a background as a management consultant in New Zealand and Australia. What was the situation of the generics market when you arrived in the Philippines and how has it evolved over the last three years? When I first arrived in the Philippines, the generics market was…

Philippines In an exclusive interview, Benjamin Liuson, president of The Generics Pharmacy in the Philippines on the company’s illustrious history, remarkable growth, and increasing acceptance of generics more generally in the Philippines. The Generics Pharmacy originated from a family business and you are the visionary who transformed it into what it…

Novartis Healthcare Philippines We have interviewed Novartis in several emerging markets including Colombia, Turkey, South Korea and Thailand. As the South East Asia Cluster Head, what is the importance of the South East Asia region for Novartis and what role do you feel the emerging markets play for the company? More companies are…

IMS Health Philippines You worked as a Country Manager in Indonesia and Thailand prior to joining IMS Health in the Philippines. What, in your opinion, sets this market apart? For starters, Indonesia is dominated by domestic players that, together, constitute 70% of the market. In the Philippines we see quite the opposite— a…

Novo Nordisk Pharmaceuticals (Philippines) Given that Asia is leading growth in the global pharmaceutical market, how is Novo Nordisk represented in the Asia-Pacific region and what is the importance of the Philippines within the company’s strategy for Asia? The Philippines is part of what we call BAOS – Business Area Oceana, which includes Australia…

GlaxoSmithKline Philippines GSK is currently the world’s fourth biggest pharmaceutical company. What is the positioning of GSK in the Philippines? GSK is the market leader among the multinational pharma companies in the Philippines, while we are number two in terms of the total market behind Unilab, which is a local company. GSK…